Wellington Management Group LLP 13D and 13G filings for Alnylam Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 10:34 am Sale | 2024-09-30 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | Wellington Management Group LLP | 5,018,779 3.910% | -2,234,128 (-30.80%) | Filing |
| 2024-02-09 08:40 am Purchase | 2023-12-29 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | Wellington Management Group LLP | 7,252,907 5.780% | 991,265 (+15.83%) | Filing |
| 2023-02-06 2:43 pm Sale | 2022-12-30 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | Wellington Management Group LLP | 6,261,642 5.090% | -578,179 (-8.45%) | Filing |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | Wellington Management Group LLP | 6,839,821 5.720% | -3,217,119 (-31.99%) | Filing |
| 2021-02-03 1:33 pm Sale | 2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY | Wellington Management Group LLP | 10,056,940 8.660% | -4,229,534 (-29.61%) | Filing |